Drug Profile
Salbutamol oral - Merck
Alternative Names: Albuterol oral - Schering-Plough; Proventil; Proventil Repetabs; Proventil Syrup; Salbutamol oral - Schering-Plough; SCH 13949W oral - Schering-PloughLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Schering-Plough
- Developer Key Pharmaceuticals; Merck & Co
- Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Small molecules; Tocolytics
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Asthma
- Discontinued Facioscapulohumeral muscular dystrophy
Most Recent Events
- 30 Jun 1998 Investigation in Facioscapulohumeral muscular dystrophy in USA (PO)
- 30 Jun 1998 Launched for Asthma in USA (PO)